Conc. (µg/mL) | ChNPs | PE | PELChNPs | Vinblastine sulfate | ||||
---|---|---|---|---|---|---|---|---|
Viability % | Inhibitory % | Viability % | Inhibitory % | Viability % | Inhibitory % | Viability % | Inhibitory % | |
500 | 34.76 | 65.24±2.48 | 2.78 | 97.22±0.16 | 1.36 | 98.64±0.21 | 5.49 | 94.51±0.23 |
250 | 58.19 | 41.81±2.07 | 9.47 | 90.53±0.39 | 4.29 | 95.71±0.07 | 7.82 | 92.18±0.16 |
125 | 80.65 | 19.35±1.39 | 17.52 | 82.48±0.74 | 9.85 | 90.15±0.13 | 15.18 | 84.82±0.49 |
62.5 | 98.42 | 1.58±0.64 | 38.17 | 61.83±1.29 | 20.64 | 79.36±0.22 | 23.87 | 76.13±1.59 |
31.25 | 100 | 0.0 | 60.95 | 39.05±2.71 | 36.79 | 63.21±0.83 | 31.95 | 68.05±0.72 |
15.6 | 100 | 0.0 | 74.82 | 25.18±1.64 | 48.63 | 51.37±1.09 | 40.56 | 59.44±1.18 |
7.8 | 100 | 0.0 | 91.43 | 8.57±0.59 | 79.41 | 20.59±1.75 | 47.21 | 52.79±2.35 |
3.9 | 100 | 0.0 | 99.56 | 0.44±0.12 | 90.64 | 9.36±0.52 | 52.94 | 47.06±1.78 |
2 | 100 | 0.0 | 100 | 0.0 | 97.23 | 2.77±0.31 | 58.76 | 41.24±0.24 |
1 | 100 | 0.0 | 100 | 0.0 | 99.52 | 0.48±0.16 | 67.16 | 32.84±0.32 |
0 | 100 | 0.0 | 100 | 0.0 | 100 | 0.0 | 100 | 0.0 |
IC50 | 337.38 ± 13.68 µg/mL | 46.27 ± 1.94 µg/mL | 15.25 ± 0.54 µg/mL | 5.91 ± 0.43 µg/mL |